Despite FDA, DOH warning, House to probe possible use of ivermectin as COVID-19 treatment

By Daniel Manalastas

The House Health Committee will be conducting an inquiry tomorrow into the national government’s COVID-19 response, and get updates on government mass testing, contact tracing, vaccination, isolation facilities, treatment, and other efforts.

Aside from these matters, they are also expected to tackle the possible use of ivermectin as treatment for COVID-19, despite warnings from the Department of Health (DOH) and Food and Drug Administration (FDA).

House Health Committee Chairperson Angelina “Helen” Tan says they “want to know what causes the skyrocketing spike in cases” and “the status of the government’s contact tracing efforts…”

Tan, who is also a medical doctor, also wants to explore other possible treatments available.

“We want to know what treatments are available out there so we can save as many patients as possible from this deadly disease,” Tan said.

House Speaker Lord Allan Velasco has authorized Tan’s committee to conduct an inquiry.

Last March 25, 1-PACMAN party-list Rep. Enrico Pineda filed House Resolution No. 1684 requesting the FDA to explain its decision on ivermectin.

The DOH and FDA warned against the purchase and use of ivermectin which is considered a veterinary product at present and “only approved for use in the prevention of heartworm disease and treatment of internal and external parasites in certain animal species.”

Anakalusugan Rep. Mike Defensor, who tested positive for COVID-19 three weeks ago, claimed that he took ivermectin twice during his illness.

“During the course of my sickness, I took ivermectin twice within the span of 14 days along with multivitamins, Lin Hua for 7 days, zinc, and fish oil vitamin. I regularly take multivitamins and fish oil even without sickness,” he said.

Defensor said he is now COVID-19 negative but still under quarantine

Popular

PBBM to endorse ‘best’ candidate for 2028 presidential race

By Ruth Abbey Gita-Carlos | Philippine News Agency President Ferdinand R. Marcos Jr. on Friday said he will endorse the “best” candidate in the 2028...

PBBM: Pax Silica a ‘good deal’ to attract more investments

By Ruth Abbey Gita-Carlos | Philippine News Agency President Ferdinand R. Marcos Jr. on Friday described the Pax Silica initiative as a “good deal,” saying...

Palace defends P7.2T budget, urges critics to study spending plan

By Darryl John Esguerra | Philippine News Agency Malacañang on Thursday hit back at critics of the proposed P7.2-trillion 2027 national budget, telling lawmakers to...

Palace: PBBM has no personal knowledge of DPWH ‘leadership fund’

By Darryl John Esguerra | Philippine News Agency President Ferdinand R. Marcos Jr. has no personal knowledge of the so-called “leadership fund” in the Department...